S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
OTCMKTS:VIVXF

Avivagen (VIVXF) Stock Price, News & Analysis

$0.0028
0.00 (0.00%)
(As of 03/28/2024 ET)
Today's Range
$0.0028
$0.0028
50-Day Range
N/A
52-Week Range
$0.00
$0.04
Volume
N/A
Average Volume
1,685 shs
Market Capitalization
$213,647.50
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
VIVXF stock logo

About Avivagen Stock (OTCMKTS:VIVXF)

Avivagen Inc. focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in Canada, Mexico, Brazil, the Philippines, Taiwan, and Thailand. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.

VIVXF Stock Price History

VIVXF Stock News Headlines

Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
See More Headlines
Receive VIVXF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avivagen and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
3/28/2024
Next Earnings (Estimated)
6/04/2024
Fiscal Year End
10/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Private households
Sub-Industry
N/A
Current Symbol
OTCMKTS:VIVXF
CIK
N/A
Fax
N/A
Employees
13
Year Founded
N/A

Profitability

Net Income
$-4,710,000.00
Net Margins
-645.05%
Pretax Margin
-645.42%

Debt

Sales & Book Value

Annual Sales
$730,000.00
Book Value
($0.06) per share

Miscellaneous

Free Float
76,063,000
Market Cap
$213,647.50
Optionable
Not Optionable
Beta
0.05
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Mr. G. F. Kym Anthony (Age 68)
    CEO & Vice Chairman
    Comp: $267.49k
  • Dr. Graham Burton Ph.D.
    Co-Founder, Chief Scientific Officer & Director
  • Mr. Ira Levy
    Interim Chief Financial Officer
  • Dr. James Nickerson Ph.D.
    President and Executive VP of Business Development & Product Innovation
  • Mr. Drew Basek
    Director of Investor Relations
  • Ms. Tracy Gillett BVSC
    Director of Companion Animal & Marketing Manager

VIVXF Stock Analysis - Frequently Asked Questions

How have VIVXF shares performed in 2024?

Avivagen's stock was trading at $0.0006 at the beginning of 2024. Since then, VIVXF stock has increased by 358.3% and is now trading at $0.0028.
View the best growth stocks for 2024 here
.

Are investors shorting Avivagen?

Avivagen saw a decrease in short interest in the month of February. As of February 29th, there was short interest totaling 24,300 shares, a decrease of 29.2% from the February 14th total of 34,300 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is presently ∞ days.
View Avivagen's Short Interest
.

When is Avivagen's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 4th 2024.
View our VIVXF earnings forecast
.

How do I buy shares of Avivagen?

Shares of VIVXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:VIVXF) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners